Skip to main content
Premium Trial:

Request an Annual Quote

Rob Martienssen and Saraswathy Nochur

Premium

Rob Martienssen, a plant genomics researcher at Cold Spring Harbor Laboratory, has been appointed a fellow of the Royal Society of London.

Martienssen is also a co-founder of Orion Genomics. He holds a BA from Cambridge University, and a PhD from the Plant Breeding Institute and Cambridge University.


Alnylam Pharmaceutics said that it has appointed Saraswathy Nochur as vice president of regulatory affairs.

She will be responsible for "leading the global regulatory strategy for the company's development-stage programs and overseeing regulatory operations," the company said.

Most recently, Nochur was vice president of regulatory affairs at The Medicines Company. Before that, she was director of product development and regulatory affairs at CereMedix. She holds a BS and MS in microbiology from the University of Bombay, and a PhD in engineering for the Massachusetts Institute of Technology.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.